Findeklee S, Lotz L, Heusinger K, Hoffmann I, Dittrich R, Beckmann M (2015)
Publication Type: Journal article
Publication year: 2015
Book Volume: 75
Pages Range: 1243-1249
Journal Issue: 12
Protecting the fertility of patients with oncologic disease is becoming more and more important, as fulfilling the wish to have children is increasingly occurring at a later stage in life and long-term survival rates after cancer are continuing to improve. A number of fertility-preserving options exist. In addition to techniques which have been around for some time such as medical ovarian suppression, ovarian transposition, and organ-preserving surgery, there are other, more recent, innovative methods which have developed over the last few years such as cryopreservation of oocytes or ovarian tissue transplantation after completing cancer therapy. As every procedure has its specific advantages and disadvantages, informed patient consent is essential. The physician's aim must be to select the optimal procedure for each patient. The extent of patients' information about the options to preserve fertility in women with oncologic disease remains limited. One of the main reasons for this is that clinicians are not sure how to inform patients about existing procedures and methods. The aim of this review article is to provide help in clinical practice.
APA:
Findeklee, S., Lotz, L., Heusinger, K., Hoffmann, I., Dittrich, R., & Beckmann, M. (2015). Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled? Geburtshilfe und Frauenheilkunde, 75(12), 1243-1249. https://doi.org/10.1055/s-0035-1558184
MLA:
Findeklee, S., et al. "Fertility Protection in Female Oncology Patients: How Should Patients Be Counseled?" Geburtshilfe und Frauenheilkunde 75.12 (2015): 1243-1249.
BibTeX: Download